The AXGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AXGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AXGN Detailed Price Forecast - CNN Money||View AXGN Detailed Summary - Google Finance|
|View AXGN Detailed Summary - Yahoo! Finance||View AXGN Stock Research & Analysis - Zacks.com|
|View AXGN Trends & Analysis - Trade-Ideas||View AXGN Major Holders - Barrons|
|View AXGN Call Transcripts - NASDAQ||View AXGN Breaking News & Analysis - Seeking Alpha|
|View AXGN Annual Report - CompanySpotlight.com||View AXGN OTC Short Report - OTCShortReport.com|
|View AXGN Fundamentals - TradeKing||View AXGN SEC Filings - Bar Chart|
|View Historical Prices for AXGN - The WSJ||View Performance/Total Return for AXGN - Morningstar|
|View the Analyst Estimates for AXGN - MarketWatch||View the Earnings History for AXGN - CNBC|
|View the AXGN Earnings - StockMarketWatch||View AXGN Buy or Sell Recommendations - MacroAxis|
|View the AXGN Bullish Patterns - American Bulls||View AXGN Short Pain Metrics - ShortPainBot.com|
|View AXGN Stock Mentions - StockTwits||View AXGN Stock Mentions - PennyStockTweets|
|View AXGN Stock Mentions - Twitter||View AXGN Investment Forum News - Investor Hub|
|View AXGN Stock Mentions - Yahoo! Message Board||View AXGN Stock Mentions - Seeking Alpha|
|View Insider Transactions for AXGN - SECform4.com||View Insider Transactions for AXGN - Insider Cow|
|View AXGN Major Holdings Summary - CNBC||View Insider Disclosure for AXGN - OTC Markets|
|View Insider Transactions for AXGN - Yahoo! Finance||View Institutional Holdings for AXGN - NASDAQ|
|View AXGN Stock Insight & Charts - FinViz.com||View AXGN Investment Charts - StockCharts.com|
|View AXGN Stock Overview & Charts - BarChart||View AXGN User Generated Charts - Trading View|
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
Posted on Wednesday May 23, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, president and CEO, will present at the Jefferies Global Healthcare Conference in New York City. AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body.
AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board
Posted on Monday May 21, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board. “As the founder of AxoGen, it has been a tremendous privilege to initiate and develop truly revolutionary products that improve quality of life for patients with peripheral nerve damage,” stated Jamie Grooms.
AxoGen, Inc. Announces Closing of Public Offering of Common Stock
Posted on Monday May 14, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock, at a price to the public of $41.00 per share. The number of shares sold by AxoGen includes an aggregate of 450,000 shares of common stock offered and sold pursuant to an option granted to the underwriters that was exercised in full. The total net proceeds from the offering for AxoGen are estimated to be approximately $132,463,000, after deducting underwriting discounts and commissions and other estimated offering expenses payable by AxoGen.
AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
Posted on Wednesday May 09, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has priced an underwritten public offering of 3,000,000 shares of its common stock, which was upsized from the previously announced 2,000,000 shares, at a price of $41.00 per share, resulting in gross proceeds (before underwriting discounts and offering expenses) to the Company of approximately $123,000,000. In addition, AxoGen has granted the underwriters a 30-day option to purchase up to an aggregate of 450,000 shares of common stock at the same price. AxoGen intends to use the net proceeds from the proposed offering for long term facility and capacity expansion and general corporate purposes.